The Next Phase: Exploring Innovation in Clinical Trials Technology and Streamlining Clinical Operations
Mar 18, 2021
Suji Shetty, Executive Vice President at Maxis Medical, brings her expertise in regulatory and clinical work to the conversation. She discusses how technology is revolutionizing clinical operations, particularly in the wake of COVID-19. The shift to digital solutions enhances patient enrollment and balances remote interactions with personal care. Suji also sheds light on rapid vaccine development, clarifying myths around mRNA technology. Key insights into pandemic collaboration reveal how transparency can drive innovation and improve patient outcomes in clinical trials.
AI Snips
Chapters
Transcript
Episode notes
COVID Accelerated Digital Adoption
- COVID-19 accelerated the adoption of digital technology in clinical research globally.
- Companies leveraging electronic medical records and digital trial files adapted better.
Balance Remote and Onsite Monitoring
- Balance remote monitoring with onsite visits to maintain strong site relations.
- Use digital oversight cautiously and address data security concerns.
Future of Clinical Operations Split
- Future clinical operations might be 90% remote and 10% onsite due to regulatory needs.
- A human touch remains essential for complex studies and site training.